Phio Pharmaceuticals (PHIO)

Phio Pharmaceuticals (PHIO) Financial Statements


Phio Pharmaceuticals Financial Overview

Phio Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-8.165; its P/E ratio is -0.08; Phio Pharmaceuticals is scheduled to report earnings on March 27, 2024, and the estimated EPS forecast is $-1.30. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -2.78M$ -2.55M$ 3.60M$ -2.73M$ -3.57M
EBITDA$ -2.73M$ -2.50M$ 3.65M$ -2.68M$ -3.56M
Net Income Common Stockholders$ -2.78M$ -2.55M$ 3.60M$ -2.73M$ -3.58M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 8.41M$ 11.31M$ 9.04M$ 11.78M$ 14.48M
Total Assets$ 9.54M$ 12.30M$ 9.71M$ 12.81M$ 15.79M
Total Debt$ 70.00K$ 104.00K$ 138.00K$ 170.00K$ 202.00K
Net Debt$ -8.34M$ -11.20M$ -8.90M$ -11.61M$ -14.28M
Total Liabilities$ 2.33M$ 2.39M$ 2.40M$ 1.97M$ 2.26M
Stockholders Equity$ 7.21M$ 9.90M$ 7.31M$ 10.84M$ 13.53M
Cash Flow-
Free Cash Flow$ -2.90M$ -2.81M$ -2.68M$ -2.71M$ -3.53M
Operating Cash Flow$ -2.90M$ -2.80M$ -2.68M$ -2.71M$ -3.53M
Investing Cash Flow-$ -5.00K--$ -7.00K
Financing Cash Flow-$ 5.05M$ -38.00K$ 2.00K$ -3.00K
Currency in USD

Phio Pharmaceuticals Earnings and Revenue History

Phio Pharmaceuticals Debt to Assets

Phio Pharmaceuticals Cash Flow

Phio Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis